Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ISCOMATRIX

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
The ISCOMATRIX adjuvant has antigen delivery and presentation properties as well as immunomodulatory capabilities, which combine… Expand
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2010
Highly Cited
2010
Truncated recombinant dengue virus envelope protein subunits (80E) are efficiently expressed using the Drosophila Schneider-2 (S2… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Review
2009
Review
2009
Immunostimulatory complexes (ISCOMs) are particulate antigen delivery systems composed of antigen, cholesterol, phospholipid and… Expand
Highly Cited
2009
Highly Cited
2009
Cancer vaccines aim to induce antitumor CTL responses, which require cross-presentation of tumor Ag to CTLs by dendritic cells… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Review
2009
Review
2009
Adjuvants are components that when added to subunit antigen (Ag) vaccines boost their immunogenicity and thus immune efficacy… Expand
Review
2007
Review
2007
The ISCOMATRIX™ adjuvant has antigen-delivery and -presentation properties, as well as immunomodulatory capabilities that combine… Expand
Review
2005
Review
2005
The immunostimulating complex, referred to as 'iscom', was first described by Morein et al. in 1984 as a novel structure for… Expand
Highly Cited
2004
Highly Cited
2004
NY-ESO-1 is a "cancer-testis" antigen expressed in many cancers. ISCOMATRIX is a saponin-based adjuvant that induces antibody and… Expand
2004
2004
Human Papillomavirus type 16 (HPV16) E6 and E7 oncoproteins are associated with cervical cancer development and progression and… Expand
Highly Cited
2003
Highly Cited
2003
Mucosal delivery of inactivated vaccines that are able to elicit protective immune responses against respiratory diseases has… Expand